Pfizer Chooses UnitedLex to Manage Document Review Services

  Pfizer Chooses UnitedLex to Manage Document Review Services

         UnitedLex Recognized as the Leader in Global Document Review

Business Wire

OVERLAND PARK, Kan. -- June 5, 2013

UnitedLex, a global provider of legal and business technology consulting
services, announces it has been selected to be the primary managed document
review provider to Pfizer Inc. [NYSE: PFE], the world's largest research-based
pharmaceutical company.

UnitedLex will ensure global delivery of Pfizer’s extensive managed document
review process by supporting real-time communications with internal and
external counsel through the most advanced video conferencing capabilities,
rigorous quality control processes, daily metrics reporting, proprietary
multi-shore workflow and defined project intake and delivery methods.
UnitedLex manages document review for Fortune 500 companies and AmLaw 100 law
firms from facilities in the United States, India, the United Kingdom and

“Pfizer has been an innovator in restructuring the litigation management
process and being selected to control one of its most critical functions is an
honor,” said Dave Deppe, President of UnitedLex. “With more than 750
professionals in nine global offices and two data centers, UnitedLex is
ideally suited to partner with a company of Pfizer’s caliber and

“Pfizer’s discovery model calls for a collaborative partner with extensive
global delivery capability that embraces the operational efficiencies and
advanced technologies required in today’s discovery environment, while also
remaining cognizant of the cost pressures large corporations face,” said Ed
Gramling, Pfizer’s Discovery Counsel. “UnitedLex has proven they can deliver a
superior work product in conjunction with highly competitive pricing and we
are excited to have them on board.”

“Each year UnitedLex handles large, complex, ‘bet-the-company’ litigation
matters for the world’s best-run companies. We look forward to the opportunity
to apply our expertise to Pfizer’s most important litigation matters,” said
Ryan Reeves, Senior Vice President of U.S. Operations for UnitedLex.

UnitedLex was awarded the position of Pfizer’s primary global document review
provider after several pilot projects, intense calibration and scalability
exercises, rigorous quality validations and many in depth operational and
security audits. Toward the end of the diligence period, members of Pfizer’s
legal team traveled to the UnitedLex Gurgaon, India facility in January of
2013. UnitedLex executives were joined by Pfizer’s Ed Gramling, Discovery
Counsel, Grace Park, Senior Corporate Counsel and Anthony Mosquera, Senior
Legal Discovery Manager to perform an in depth analysis of UnitedLex’s global
operations. Ryan Reeves will lead the initiative on behalf of UnitedLex to
ensure continued improvements across the established Pfizer Discovery platform
with ultimate focus on quality of work product delivered from the UnitedLex
global delivery platform.

About UnitedLex

UnitedLex ( is a global company with a singular mission to
improve the performance of law departments and law firms. We provide
unparalleled solutions to address the risk, efficiency and effectiveness goals
of our clients in North America, Europe and Asia. Our more than 750 attorneys,
engineers and consultants focus on the broadly defined areas of litigation,
contracting, intellectual property and operations to drive seven and eight
figure benefit to our clients. Founded in 2006 and with more than $250 million
in assets, UnitedLex deploys the right blend of service and technology in
supporting the world’s leading corporations and law firms.


Kristie Kushner, 1-678-575-7558
Infinite PR
Jamie Diaferia, 212-687-0935
Press spacebar to pause and continue. Press esc to stop.